MacroGenics | MGNX - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 364.22B 20.46B 2026-05
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Genmab DKK 20.48B 1.02B 2025-12
Geron USD 946M 9M 2026-05
Gilead Sciences USD 167.39B 5.6B 2026-05
J&J USD 579.15B 78.91B 2026-03
Karyopharm Therapeutics USD 956M 821M 2026-05
MacroGenics USD 102M 4M 2025-12
Merck USD 297.1B 35.84B 2026-03
Pfizer USD 147.4B 6.42B 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Xencor USD 795M 98M 2026-05